CIDRAP newsletters options
Dec 11, 2009
Dec 10, 2009
(CIDRAP News) Another month's worth of data on H1N1 influenza has led federal officials to more than double their estimates of total cases, hospitalizations, and deaths and to assert that the impact on children and younger adults has been far greater than that of a typical flu season.
North Korea confirms flu outbreak
(CIDRAP News) About the same percentage of Americans were vaccinated against seasonal influenza this year as received vaccine last year, according to a survey released today that undercuts perceptions of extraordinary demand driven by pandemic-fueled awareness.
(CIDRAP News) Researchers who analyzed H1N1 influenza hospitalization and death data from the early months of the pandemic say the fall-winter phase of the contagion may bring fewer deaths than an average flu season, barring any changes that would make the virus more virulent, but the deaths are likely to be in younger age-groups.
Dec 9, 2009 (CIDRAP News) In an update of a review on the role of neuraminidase inhibitors in seasonal flu prevention and treatment, the authors reversed a previous conclusion that oseltamivir (Tamiflu) prevents complications like pneumonia in healthy patients because they were unable to reconstruct the data in one of the key studies that found a benefit.
South Korea may aid North Korea's flu fight
Dec 7, 2009
(CIDRAP News) Preliminary studies indicate that the pandemic H1N1 vaccine is just as safe as seasonal flu vaccines and is very unlikely to increase the risk of the paralytic condition that derailed the 1976 swine flu vaccination campaign, the Centers for Disease Control and Prevention (CDC) said today.
Dec 4, 2009
Johns Hopkins finds resistant strain in 2 patients
(CIDRAP News) – The World Health Organization's (WHO's) top influenza expert said today it's too soon to judge whether the H1N1 influenza pandemic has passed its peak, though he acknowledged that cases are dropping in the United States and Canada.
Dec 2, 2009
(CIDRAP News) A second seasonal influenza vaccine made by Novartis was approved recently by the US Food and Drug Administration (FDA), and the company said some doses may reach the market this flu season.
(CIDRAP News) The World Health Organization (WHO) said today that oseltamivir (Tamiflu)-resistant pandemic H1N1 cases in hospital settings suggest that treatment doses may need to be increased in immunocompromised patients who have flu symptoms.
The agency made this statement after a teleconference with experts about two recent clusters of resistant cases. It also concluded that the events don't signal a public health threat.
Dec 1, 2009
